Fibrocystic mastopathy - pathology,characterized by the formation of benign seals. This pathology occurs when the hormonal status of the organism is violated. It should be noted that women of the reproductive age are the most sensitive to the disease.
The pathogenesis of the disease is clearly related to the physiologicalfeatures of the female body. Reproductive age is characterized by manifestations of a two-phase menstrual cycle, which is regulated by female sex hormones (estrogen, progesterone). These hormones also affect proliferation (multiplication) of breast cells. The hormone progesterone is synthesized during the II phase of the menstrual cycle, it inhibits cell proliferation. During the individual menstrual cycle, the mammary glands increase in volume, swell, and then return to normal. As a result of the action of hormones, the mammary glands increase in volume, and the milk ducts narrow down. All this leads to fluid retention in the tissues of the breast. Therefore, the chest during this period becomes very sensitive and painful, sometimes under the skin palpable nodules. As a rule, after menstruation, these painful sensations pass, and nodules and hypersensitivity disappears.
In this regard, the best period forA breast examination is the seventh or tenth day after the onset of the menstrual cycle. At this time, breast tissue is in its normal state. Under the influence of various factors, a kind of imbalance of hormones develops. Diffuse fibrotic mastopathy can also occur due to an excessive amount of prolactin in the body. This hormone is produced by the adenohypophysis. Normally, prolactin is synthesized during pregnancy and lactation. Important factors in the development of mastopathy are microelementoses, depression, smoking, neuroses, abortions, breast trauma, alcohol consumption, etc.
Fibrocystic mastopathy is diagnoseddoctor-mammologist. Additional methods of research are biopsy and mammography. Fortunately, only 5% of cases reveal fibrocystic changes, which can cause a malignant tumor.
Fibrous mastopathy: treatment.
The scheme of therapeutic actions depends mainly on the type and etiology of the disease. Treatment of mastopathy is carried out conservatively or surgically.
Fibrocystic mastopathy: hormone therapy.
Treatment is aimed at optimizing andrestoration of the hormonal background of the body. This type of therapy is carried out with the use of the following drugs: oral estrogen-gestagennye contraceptives ("Marvelon", "Zhanin"), recommend women under thirty-five years of age under a special scheme; antiestrogenic drugs ("Tamoxifen", "Fareston") are taken for three months with daily use; gestagenic preparations ("Utrozhestan", "Dyufaston") are appointed in the II phase of the cycle of menstruation from 15 to 25 days; to reduce the formation of prolactin prescribe the drug "Parlodel", which is taken from 10 to 25 days of the monthly cycle; male sex hormones - androgens ("Methyltestosterone") are taken from the 16th to the 25th day of the female cycle, but these hormones are prescribed rarely, because they are the cause of increased hair loss.
Fibrocystic mastopathy: non-hormonal treatment.
To do this, non-hormonal drugs are prescribed:phytopreparations, vitamins, as well as anti-inflammatory drugs ("Dicloburn", "Diclofenac"). Recently, the most popular drug for the treatment of mastopathy is Mastodin. The mechanism of its action is aimed at reducing the concentration of the hormone-prolactin in the blood. This in turn contributes to the elimination of inflammatory processes in the parenchyma of the breast. The drug "Mastodin" perfectly removes the main symptoms of the disease. Patients whose etiology of the disease is associated with neuroses, stresses or depressions, are prescribed sedentary therapy. Good substitution therapy with vitamins (A, E, B and C), antioxidants, and preparations of Yod, Zinc and Selen (Selenium-Active, Zincosan, Yodomarin, Yodditzerin, Yod -activity "," Yodtiroks ").
